Barclays Maintains an 'Equalweight' on Abbott Labs (ABT); Business Review & Form 10 Filing
Tweet Send to a Friend
Barclays maintains an 'Equalweight' on Abbott Labs (NYSE: ABT) price target of $55.00.
Analyst, C. Anthony Butler, commented on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst, C. Anthony Butler, commented on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
